[{"bbox": [97, 121, 438, 147], "category": "Section-header", "text": "### Outcome 1 (or Specific Objective 1)"}, {"bbox": [97, 148, 1132, 204], "category": "List-item", "text": "1.1 Improved and upgraded R&D Unit capable of researching, developing, producing active pharmaceutical ingredients (IPAs) and operating the characterization laboratory."}, {"bbox": [97, 204, 1132, 259], "category": "List-item", "text": "1.2 Training of professionals at CIGB Mariel in state of the art production of IPAs and international production and laboratory standards."}, {"bbox": [97, 275, 438, 302], "category": "Section-header", "text": "### Outcome 2 (or Specific Objective 2)"}, {"bbox": [97, 303, 1132, 386], "category": "List-item", "text": "2.1 Modernized NRA Control Laboratory with infrastructures, metrology and analytical capacities compatible with international standards for the development, production and control of medicines and biotechnological products."}, {"bbox": [97, 386, 922, 413], "category": "List-item", "text": "2.2 Improved capacity of NRA for electronic management of data and business processes."}, {"bbox": [97, 413, 1132, 465], "category": "List-item", "text": "2.3 Improved capacities of staff of CECMED in the European Union's official standards for the control of medicines, for certification by WHO and for communication."}, {"bbox": [97, 466, 1132, 520], "category": "List-item", "text": "2.4 Increased capacity of CECMED specialists on international research project management and public procurement."}, {"bbox": [97, 534, 438, 561], "category": "Section-header", "text": "### Outcome 3 (or Specific Objective 3)"}, {"bbox": [97, 562, 1132, 616], "category": "List-item", "text": "3.1 Improved capacity of young professionals from Cuba's Biopharmaceutical Industry network, the University of Havana Startups and new SMEs on the biotechnological products for priority diseases and health emergencies."}, {"bbox": [97, 617, 1132, 672], "category": "List-item", "text": "3.2 Improved capacities of biotechnological industry professionals and NRA for international research project management, with an emphasis on the EU biotechnological sector and related health areas."}, {"bbox": [97, 673, 1132, 756], "category": "List-item", "text": "3.3 Improved capacities of biotechnological industry professionals, NRA, SMEs and Havana University in scientific writing for publication of relevant Cuban biotechnological research in peer reviewed international journals, with a particular attention for publications of female authors."}, {"bbox": [97, 757, 1047, 784], "category": "List-item", "text": "3.4 Enhanced capacities in the international publication of the impact of biotechnology research results."}, {"bbox": [97, 784, 1132, 839], "category": "List-item", "text": "3.5 A proposal developed, in synergy with the LAIF program supporting the health sector and the network of SUMA laboratories to develop of an epidemiological intelligence system."}, {"bbox": [145, 901, 418, 929], "category": "Section-header", "text": "## 3.2 Indicative activities"}, {"bbox": [97, 947, 477, 972], "category": "Section-header", "text": "### Activities related to Specific Objective 1:"}, {"bbox": [135, 973, 1132, 1079], "category": "List-item", "text": "1. Purchase of technological equipment for the research and development areas dedicated to the production of active pharmaceutical ingredients (API) for the production of batches for clinical trials at the CIGB Mariel plant. The specification of the equipment shall be adapted to the evolving needs at the time of acquisition."}, {"bbox": [135, 1079, 1132, 1159], "category": "List-item", "text": "2. Technological upgrade to strengthen laboratory capacities for physico-chemical and biological characterization of products at the CIGB Mariel plant. The specification of the equipment shall be adapted to the evolving needs at the time of acquisition."}, {"bbox": [135, 1159, 1132, 1212], "category": "List-item", "text": "3. Provision and installation of technological infrastructure for the creation and development of a technological classroom linked to face-to-face or virtual integral skills at the Mariel CIGB."}, {"bbox": [135, 1212, 1000, 1239], "category": "List-item", "text": "4. Development of workshops and seminars linked to capacity building needs in the industry."}, {"bbox": [135, 1239, 833, 1266], "category": "List-item", "text": "5. Technical assistance according to the needs of the equipment purchased."}, {"bbox": [97, 1280, 472, 1305], "category": "Section-header", "text": "### Activities related to Specific Objective 2"}, {"bbox": [135, 1306, 1132, 1385], "category": "List-item", "text": "1. Strengthen actions to ensure the metrological traceability of RNA quality control trials of medicines and vaccines. The specification of the equipment shall be adapted to the evolving needs at the time of acquisition."}, {"bbox": [135, 1385, 1132, 1439], "category": "List-item", "text": "2. Technological upgrade of the CECMED National Control Laboratory. The specification of the equipment shall be adapted to the evolving needs at the time of acquisition."}, {"bbox": [135, 1439, 1132, 1491], "category": "List-item", "text": "3. Provision and installation of technological infrastructure for the electronic management of the technical and administrative processes of the National Medicines Regulatory Authority."}, {"bbox": [135, 1491, 1132, 1543], "category": "List-item", "text": "4. Participation of the NRA in collaborative trials or proficiency tests between Quality Control Laboratories for Medicinal Products."}, {"bbox": [135, 1544, 1132, 1600], "category": "List-item", "text": "5. High-level and technical international exchanges for the development of cooperation, preparation and networking activities with a view to certification as a WHO listed Authority."}, {"bbox": [1037, 1680, 1143, 1705], "category": "Page-footer", "text": "Page 7 of 24"}]